T226-1621 Screening compound: 5-benzyl-7-(morpholine-4-carbonyl)-4H,5H-pyrazolo[1,5-a]quinoxalin-4-one

T226-1621 Screening compound: 5-benzyl-7-(morpholine-4-carbonyl)-4H,5H-pyrazolo[1,5-a]quinoxalin-4-one
T226-1621 Screening compound: 5-benzyl-7-(morpholine-4-carbonyl)-4H,5H-pyrazolo[1,5-a]quinoxalin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound T226-1621
5-benzyl-7-(morpholine-4-carbonyl)-4H,5H-pyrazolo[1,5-a]quinoxalin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T226-1621

Molecular Formula

C22H20N4O3 (C22 H20 N4 O3)

Compound Name

5-benzyl-7-(morpholine-4-carbonyl)-4H,5H-pyrazolo[1,5-a]quinoxalin-4-one

IUPAC name

5-benzyl-7-(morpholine-4-carbonyl)-4H5H-pyrazolo[15-a]quinoxalin-4-one

SMILES

O=C(c(cc1)cc(N2Cc3ccccc3)c1-n1nccc1C2=O)N1CCOCC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

388.43

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.729

Distribution Coefficient, logD

1.729

Water Solubility, LogSw

-2.15

Polar Surface Area

52.396

Acid Dissociation Constant (pKa)

25.36

Base Dissociation Constant (pKb)

0.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

22.70

T226-1621 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Antimitotic Tubulin Library (17355 compounds)

Antiviral Library (67538 compounds)

PI3K-Targeted Library (17255 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with T226-1621 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T226-1621?
Check Price and Availability of T226-1621, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T226-1621 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T226-1621
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T226-1621
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T226-1621 available by request